Global Anti-Parkinson Drugs Market Trends, Strategies, And Opportunities In The Anti-Parkinson Drugs Market 2021-2030

Anti-Parkinson Drugs Market Report 2021 - COVID-19 Impact and Recovery

Anti-Parkinson Drugs Global Market Report 2021 – COVID-19 Impact and Recovery

The Business Research Company’s Anti-Parkinson Drugs Global Market Report 2021 – COVID-19 Impact and Recovery

LONDON, GREATER LONDON, UK, October 5, 2021 /EINPresswire.com/ — According to the new market research report ‘Anti-Parkinson Drugs Global Market Report 2021: COVID-19 Impact And Recovery’ published by The Business Research Company, the anti-Parkinson drugs market size is expected to grow from $5.3 billion in 2020 to $5.55 billion in 2021 at a compound annual growth rate (CAGR) of 4.7%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $7.78 billion in 2025 at a CAGR of 9%. The increasing geriatric population and surging cases of Parkinson’s disease (PD) are projected to drive the demand for the anti-Parkinson drugs market.

Request For A Sample For The Global Anti-Parkinson Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3462&type=smp

The anti-Parkinson drugs market consists of sales of drugs used for treating Parkinson’s disease (PD), generated by the establishments that manufacture these drugs. Parkinson’s disease is a neurodegenerative disorder that affects predominately dopaminergic neurons in a specific area of the brain named substantia nigra and disturbs the movement of the body. People suffering from PD may experience tremor, bradykinesia, limb rigidity, gait, and balance problems.

Trends In The Global Anti-Parkinson Drugs Market
Increasing investments by governments and companies for Parkinson’s disease drug R&D is a major trend in the anti-Parkinson drugs market. For instance, according to the report published in 2018 by the Parkinson’s Foundation, the foundation awarded $6 million to Parkinson’s disease (PD) research. In January 2019, Parkinson’s UK Research and Support charity in the United Kingdom announced a research investment of $1.9 million (£1.5 million) into its drug discovery program to develop novel gene transcription modulators for Parkinson’s disease. Hence, increasing investments in Parkinson’s drug development are expected to drive the Parkinson’s Disease drugs market.

Global Anti-Parkinson Drugs Market Segments:
The global anti-Parkinson’s drugs market is further segmented based on drug class, route of administration, distribution channel and geography.
By Drugs Class: Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drugs.
By Route of Administration: Oral, Injection, Transdermal.
By Distribution Channel: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies.
By Geography: The global anti-Parkinson drug market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Anti-Parkinson Drugs Market At:
https://www.thebusinessresearchcompany.com/report/anti-Parkinson-drugs-global-market-report-2020-30-covid-19-growth-and-change

Anti-Parkinson Drugs Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides anti-Parkinson drugs market overviews, analyzes and forecasts market size and growth for the global anti-Parkinson drugs market, anti-Parkinson drugs market share, anti-Parkinson drugs market players, anti-Parkinson drugs market segments and geographies, anti-Parkinson drugs market’s leading competitors’ revenues, profiles and market shares. The anti-Parkinson drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Read Anti-Parkinson Drugs Global Market Report 2021 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Anti-Parkinson Drugs Market Organizations Covered: GlaxoSmithKline plc, Pfizer, Merck, Novartis, Roche, UCB S.A, Teva Pharmaceuticals, AbbVie Inc., Mylan, Boehringer Ingelheim, Orion Pharma, ACADIA Pharmaceuticals Inc, Sun Pharma, Wockhardt, Dr. Reddy’s, Intas, US WorldMeds, Zydus Cadila, Cipla, Strides, 1 A Pharma, Upsher-Smith, Lundbeck, Vertical Pharmaceuticals, LLC, Zambon Pharmaceuticals, M Somerset Pharmaceuticals Inc., Wockhardt.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Get a quick glimpse of our services here:
https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Here is a list of reports from The Business Research Company similar to the Anti-Parkinson Drugs Global Market Report 2021:

Central Nervous System Drugs Global Market Report 2021 – By Type (Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Other CNS Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), COVID-19 Impact And Recovery
https://www.thebusinessresearchcompany.com/report/central-nervous-system-drugs-global-market-report-2020-30-covid-19-implications-and-growth

Pharmaceutical Drugs Global Market Report 2021 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorders Drugs, Musculoskeletal Disorders Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), COVID-19 Impact And Recovery
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report

Generic Pharmaceuticals Global Market Report 2021 – By Therapy (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Type (Biosimilar, Simple Generic, Super Generic), By Drug Delivery (Oral, Injectables, Dermal/Topical, Inhaler), COVID-19 Growth And Change
https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *